TP53 and neoplasm: All five EACs showed homogeneous TP53 mutations: in each EAC the same TP53 mutations (nonsynonymous somatic point mutations or splice site alterations) were identified in all investigated tumor regions, all mutations were previous described in esophageal cancer samples in the COSMIC database.